Professor Nigel Bundred is the NIHR Clinical Research Network National Specialty Lead for Surgery.
Professor Bundred is a Professor of Surgical Oncology and Consultant Surgeon based at the University Hospital of South Manchester NHS Foundation Trust in Manchester. He is also the Greater Manchester CRN Cancer Lead.
Professor Bundred’s research interests include preinvasive cancer (ductal carcinoma in situ), breast cancer chemoprevention, endocrine therapy and bone metastases and I have developed xenograft models of human DCIS, primary culture and stem cell cultures of human DCIS. His research in Manchester was recognised by the Royal College of Surgeons of England when he was appointed a Hunterian Professorship in 1995 for his work on parathyroid hormone related peptide and its role in bone metastases.
Professor Bundred has been the recipient of numerous honours and awards, including the Patey Prize from the Society of Academic & Research Surgery and the Ronald Raven Prize from the British Association of Surgical Oncology.
Professor Bundred has authored or co-authored more than 200 peer-reviewed articles and my work has appeared in many journals, including the Journal of the National Cancer Institute, The Lancet, Lancet Oncology, Cancer Research and Cancer. I was the chief investigator on several preoperative DCIS and invasive trials and the EPHOS-B trial funded by Cancer UK.